Journal of Viral Hepatitis

Papers
(The H4-Index of Journal of Viral Hepatitis is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Low risk of hepatitis B reactivation in patients with severe COVID‐19 who receive immunosuppressive therapy55
Clinical characteristics in patients with SARS‐CoV‐2/HBV co‐infection48
Ten‐year follow‐up of a randomized controlled clinical trial in chronic hepatitis delta46
Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta‐analysis41
Hepatitis E virus genome detection in commercial pork livers and pork meat products in Germany37
The impact of SVR from direct‐acting antiviral‐ and interferon‐based treatments for HCV on hepatocellular carcinoma risk34
Incidence of HCC in chronic hepatitis C patients with advanced hepatic fibrosis who achieved SVR following DAAs: A prospective study34
COVID‐19 and the Liver: Lessons Learnt from the EAST and the WEST, A Year Later31
Epidemiological and clinical characteristics of 70 cases of coronavirus disease and concomitant hepatitis B virus infection: A multicentre descriptive study31
SARS‐CoV‐2 infection in patients with a normal or abnormal liver28
Distribution and clinical characteristics of patients with chronic hepatitis B virus infection in the grey zone27
The case for simplifying and using absolute targets for viral hepatitis elimination goals27
Global cascade of care for chronic hepatitis C virus infection: A systematic review and meta‐analysis26
Altered faecal microbiota on the expression of Th cells responses in the exacerbation of patients with hepatitis E infection26
Loss to follow‐up in the hepatitis C care cascade: A substantial problem but opportunity for micro‐elimination26
Unexpected long‐lasting anti‐HEV IgM positivity: Is HEV antigen a better serological marker for hepatitis E infection diagnosis?25
Incidence of extrahepatic cancers among individuals with chronic hepatitis B or C virus infection: A nationwide cohort study25
A same day ‘test and treat’ model for chronic HCV and HBV infection: Results from two community‐based pilot studies in Egypt24
Impact of direct‐acting antiviral regimens on mortality and morbidity outcomes in patients with chronic hepatitis c: Systematic review and meta‐analysis22
Durability of hepatitis B surface antigen seroclearance and subsequent risk for hepatocellular carcinoma: A meta‐analysis22
Clinical effects of NTCP‐inhibitor myrcludex B22
Randomized clinical trials towards a single‐visit cure for chronic hepatitis C: Oral GSK2878175 and injectable RG‐101 in chronic hepatitis C patients and long‐acting injectable GSK2878175 in healthy p21
Dynamics of liver stiffness by transient elastography in patients with chronic hepatitis C virus infection receiving direct‐acting antiviral therapy—Results from the German Hepatitis C‐Registry21
0.071056127548218